chr22-20779330-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_000185.4(SERPIND1):c.18C>T(p.Asn6Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,614,210 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00095 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 30 hom. )
Consequence
SERPIND1
NM_000185.4 synonymous
NM_000185.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.687
Genes affected
SERPIND1 (HGNC:4838): (serpin family D member 1) This gene belongs to the serpin gene superfamily. Serpins play roles in many processes including inflammation, blood clotting, and cancer metastasis. Members of this family have highly conserved secondary structures with a reactive center loop that interacts with the protease active site to inhibit protease activity. This gene encodes a plasma serine protease that functions as a thrombin and chymotrypsin inhibitor. The protein is activated by heparin, dermatan sulfate, and glycosaminoglycans. Allelic variations in this gene are associated with heparin cofactor II deficiency. [provided by RefSeq, Jul 2015]
PI4KA (HGNC:8983): (phosphatidylinositol 4-kinase alpha) This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 22-20779330-C-T is Benign according to our data. Variant chr22-20779330-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2652915.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.687 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00127 (1857/1461886) while in subpopulation EAS AF= 0.0322 (1279/39700). AF 95% confidence interval is 0.0307. There are 30 homozygotes in gnomad4_exome. There are 957 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 144 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPIND1 | NM_000185.4 | c.18C>T | p.Asn6Asn | synonymous_variant | 2/5 | ENST00000215727.10 | NP_000176.2 | |
PI4KA | NM_058004.4 | c.2329-13637G>A | intron_variant | ENST00000255882.11 | NP_477352.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPIND1 | ENST00000215727.10 | c.18C>T | p.Asn6Asn | synonymous_variant | 2/5 | 1 | NM_000185.4 | ENSP00000215727.5 | ||
PI4KA | ENST00000255882.11 | c.2329-13637G>A | intron_variant | 1 | NM_058004.4 | ENSP00000255882.6 |
Frequencies
GnomAD3 genomes AF: 0.000946 AC: 144AN: 152206Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
144
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00129 AC: 323AN: 251336Hom.: 0 AF XY: 0.00129 AC XY: 175AN XY: 135850
GnomAD3 exomes
AF:
AC:
323
AN:
251336
Hom.:
AF XY:
AC XY:
175
AN XY:
135850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00127 AC: 1857AN: 1461886Hom.: 30 Cov.: 31 AF XY: 0.00132 AC XY: 957AN XY: 727242
GnomAD4 exome
AF:
AC:
1857
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
957
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000945 AC: 144AN: 152324Hom.: 1 Cov.: 32 AF XY: 0.000926 AC XY: 69AN XY: 74484
GnomAD4 genome
AF:
AC:
144
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
69
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
27
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | SERPIND1: BP4, BP7, BS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at